Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
674 Views
eMediNexus 13 January 2018
The US Food and Drug Administration (FDA) has expanded the indication for the four-strain influenza vaccine Fluarix Quadrivalent (GlaxoSmithKline) to children as young as 6 months. The vaccine is approved for use in adults and children aged 3 years and older to prevent disease due to seasonal influenza virus subtypes A and B.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}